Antimicrobial resistance continues to be a public health threat across the globe. Recent updates to the Joint omission standards provide an opportunity to evaluate our current programs for improvements. Today’s program looks at what two health organizations are doing to optimize antimicrobial utilization, mitigate antimicrobial resistance and improve patient outcomes.
Joining Vizient’s Jim Lichauer for this discussion are Michael Postelnick System Program Director of Antimicrobial and Diagnostic Stewardship at Northwestern Medicine and Lucas Schulz, Antimicrobial Stewardship Program Director and PGY1 and PGY2 for Infectious Disease at University of Wisconsin Health.
Guest speakers: Michael Postelnick, RPh BCPS AQ-Infectious Diseases System Program Director, Antimicrobial and Diagnostic Stewardship Northwestern Medicine
Lucas Schulz, PharmD, BCIDP Clinical Manager, Acute Care Services Residency Program Director – PGYI and PGY2 Infectious Diseases University of Wisconsin Health
Moderator: Jim Lichauer, PharmD, BCPS, FASHP Senior PI Program Director, Pharmacy Vizient
Show Notes:
[1:10] The Joint Commission and CMS updates are driving antimicrobial stewardship programs (ASP) forward
[3:50] EP 10 criteria to determine necessary resources to operate the stewardship program effectively and ensure that the resource allocation matches the determined needs
[5:20] EP 12 is revised to specifically require competency-based training for medical staff
[7:35] EP 20 recommends reporting ASP data to hospital leadership and prescribers
[9:45] Joint Commissions new standards include ambulatory care
[13:25] CMS rules for infection prevention and antimicrobial stewardship (CMSQSO-22-20)
Links | Resources:
Contact Knowledge on the Go: picollaboratives@vizientinc.com
Subscribe Today!
You Might Like
